{"id":280526,"date":"2025-10-05T23:46:14","date_gmt":"2025-10-05T23:46:14","guid":{"rendered":"https:\/\/www.europesays.com\/us\/280526\/"},"modified":"2025-10-05T23:46:14","modified_gmt":"2025-10-05T23:46:14","slug":"taiwan-pavilion-fostering-collaborative-innovation-in-ai-regenerative-medicine-and-cdmo-at-biojapan-2025","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/280526\/","title":{"rendered":"Taiwan Pavilion Fostering Collaborative Innovation in AI, Regenerative Medicine and CDMO at BioJapan 2025"},"content":{"rendered":"\n<p class=\"yf-1090901\">TAIPEI, Oct. 6, 2025 \/PRNewswire\/ &#8212; The\u00a0<b><a href=\"https:\/\/www.biopharm.org.tw\/en\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO);elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO)<\/a><\/b>,\u00a0an organization focused on fostering Taiwan&#8217;s biotech ecosystem, announced today that it will lead a delegation of 16 biotech industry partners from Taiwan to participate in <b>BioJapan 2025 (Yokohama, October 8-10, 2025).<\/b> Taiwan&#8217;s participation in BioJapan 2025, through the Taiwan Pavilion and delegation, will serve as an impactful forum to showcase the value that Taiwan&#8217;s ecosystem can bring to Japanese companies in jointly realizing the future of biotech innovation.<\/p>\n<p>    <a href=\"https:\/\/mma.prnewswire.com\/media\/2787768\/Taiwan_Delegation2025.html\" target=\"_blank\" rel=\"noopener noreferrer\"><img fetchpriority=\"high\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"Discover Taiwan\u2019s Innovation at BioJapan 2025\" loading=\"eager\" height=\"280\" width=\"400\" class=\"yf-1gfnohs loader\"\/><\/a> Discover Taiwan\u2019s Innovation at BioJapan 2025      <\/p>\n<p class=\"yf-1090901\"><b>BPIPO&#8217;s Participation Details at BioJapan 2025<\/b><\/p>\n<ul class=\"yf-1woyvo2\">\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><b>Booth Number: <\/b>B-77 (Taiwan Pavilion)<\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><b>Dates:<\/b>\u00a0October 8 to 10, 2025, at PACIFICO Yokohama, Yokohama, Japan<\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\"><b>&#8220;Cheers &amp; Collab&#8221; Gathering:<\/b>\u00a0October 9, from 4pm to 5pm at the Taiwan Pavilion, featuring drinks and snacks<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1090901\">At the event, BPIPO will showcase Taiwan&#8217;s cutting-edge competitiveness in high-growth sectors, including regenerative medicine, AI healthcare, precision health,\u00a0and contract development and manufacturing (CDMOs). Taiwan&#8217;s biotech ecosystem offers a unique blend of capabilities, including:<\/p>\n<ul class=\"yf-1woyvo2\">\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\">Advanced manufacturing<\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\">Regenerative medicine expertise<\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\">Robust integration of information and communications technology (ICT)<\/p>\n<\/li>\n<li class=\"yf-1woyvo2\">\n<p class=\"yf-1090901\">Pro-growth regulatory framework aligned with international standards<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1090901\"><b>Taiwanese Biotech Companies Advance in Japan\u00a0<\/b><\/p>\n<p class=\"yf-1090901\">With these capabilities, Taiwanese companies continue to flourish in Japan. In 2024, Japan&#8217;s CBC became an official distributor for Taiwan&#8217;s <b>TBMC<\/b>, allowing the company to expand its presence in the Japanese market. In addition, <b>Leeuwenhoek<\/b> successfully launched its Flora Le Light Synbiotic in Japan.<\/p>\n<p class=\"yf-1090901\">This year, <b>Amaran <\/b><b>Biotech<\/b>\u00a0established a strategic partnership with Nippon Fine Chemical to jointly enhance CDMO manufacturing technology services for nanoparticle-based drugs in Taiwan and Japan. Taiwan-Japan collaborations have also yielded a slew of developments: <b>AM Biotech&#8217;s <\/b>high-purity targeted exosomes were officially registered with the Japan Cosmetic Industry Association, and its ExoGiov exosomes have expanded from cosmetics to regenerative medicine. Another Taiwanese company, <b>LumiSTAR<\/b>,\u00a0has been selected for Takeda Pharmaceutical&#8217;s COCKPI-T\u00ae program to advance innovation in drug discovery and development.<\/p>\n<p class=\"yf-1090901\">Following the recent securing of Foreign Manufacturer Accreditation from the Japanese government, <b>Steminent<\/b> aims to achieve certification in 2026 for its new regenerative medicine, Stemchymal\u00ae. As a testament to growing collaboration, one of the delegation members, <b>Creative Life Science<\/b>, and Japan&#8217;s Myoridge will sign an MOU, combining strengths in cell culture and production channels to unleash new possibilities for regenerative medicine.<\/p>\n","protected":false},"excerpt":{"rendered":"TAIPEI, Oct. 6, 2025 \/PRNewswire\/ &#8212; The\u00a0Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO),\u00a0an organization focused on fostering Taiwan&#8217;s&hellip;\n","protected":false},"author":3,"featured_media":280527,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21],"tags":[691,738,150,144987,102528,30723,158,67,132,68,144988],"class_list":{"0":"post-280526","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-artificial-intelligence","8":"tag-ai","9":"tag-artificial-intelligence","10":"tag-biotechnology","11":"tag-cdmo","12":"tag-regenerative-medicine","13":"tag-taiwan","14":"tag-technology","15":"tag-united-states","16":"tag-unitedstates","17":"tag-us","18":"tag-yokohama"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115324228912401820","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/280526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=280526"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/280526\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/280527"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=280526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=280526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=280526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}